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Size-selectivity of the glomerular barrier to high molecular weight
proteins: Upper size limitations of shunt pathways. To evaluate the large
pore radius of the glomerular capillary filter, plasma-to-urine fractional
clearances of a number of endogenous proteins were assessed in normal
and in nephrotic Wistar rats in which proximal tubular reabsorption had
been inhibited using lysine. The proteins studied varied in radius from 16.2
Å (b2-microglobulin) to 90 Å (a2-macroglobulin). The nephrotic syn-
drome was induced by puromycin aminonucleoside (PAN). A marked
restriction of the transport of large proteins across the glomerular
capillary wall was found, indicating that there are no non-discriminatory
‘shunt pathways’ in the glomerular barrier. Rather, there seems to be large
pores of radius 110 to 115 Å accounting for the clearance of large proteins
into the primary urine. This protein excretion pattern was almost the same
for control and nephrotic rats, except that in the latter, the number of
large pores was increased 170 times. The ratio between the number of
large and small pores was calculated to be '7 z 1027 in normal rats and to
1.3 z 1024 in PAN nephrotic rats, assuming no classic shunt pathways. If
classic shunt pathways had still existed, they would normally contribute to
no more than '1025 of the total glomerular filtration rate. We postulate
that very large macromolecules like IgM will not pass the glomerular filter
at all under normal conditions, whereas the urine concentration of
a2-macroglobulin will normally be extremely low.
The passage of solutes from blood to interstitium in the body
can be adequately described by a two-pore theory of capillary
permeability [1–3]. This theory predicts the transcapillary passage
of small solutes and water to occur mainly through equivalent
‘small pores’ of a radius 40 to 50 Å or negatively charged pores or
slits of radius '60 Å. The passage of albumin is severely restricted
across these pores. Albumin, and even larger macromolecules, can
be modelled to pass the capillary membrane through a very small
number of ‘large pores’ or ‘shunt pathways’ having a radius of
approximately 250 Å. The two-pore theory is based on measure-
ments of steady-state fractional clearances of proteins from
plasma to interstitium or lymph.
The measurement of fractional clearances (u) of proteins across
the glomerular capillary wall to the primary urine presents
formidable problems, because a vast majority of the proteins
appearing in the Bowman’s capsule ultrafiltrate are reabsorbed in
the proximal tubules before reaching the final urine. In humans,
the urinary fractional clearance of albumin is thus of the order of
2 to 6 z 1026, whereas the corresponding fractional clearance to
the primary urine is thought to be of the order of 1 z 1024 or
slightly less. In rats, the corresponding numbers may be as high as
1 to 2 z 1024 and 1 to 2 z 1023, respectively [4, 5].
Due to the presence of proximal tubular reabsorption, endog-
enous proteins have only rarely been chosen to assess glomerular
permselectivity, except in micropuncture studies [6, 7]. However,
the latter are usually complicated by the adsorption of proteins to
the sampling pipette or by active reabsorption of proteins in
nephron segments proximal to the pipette. Other ways of over-
coming the problems caused by tubular reabsorption have been
based on inhibition of the reabsorption in, for example, isolated
kidneys, by tissue cooling to 8°C [4, 5] or using inhibitors of
tubular reabsorption such as lysine, maleate or cytochalasin B
[8–10].
In a majority of previous studies, dextrans (negatively charged
or uncharged) have been used to probe the size-selectivity of the
glomerular filter, since dextrans are neither actively reabsorbed
nor secreted. Such measurements were recently extensively re-
viewed [11]. Using uncharged dextrans, the ‘small pore’ radius in
the glomerular filter has been determined to be '50 to 55 Å both
in the human and rat. To explain the passage of macromolecules
larger than albumin across the glomerular barrier a ‘shunt path-
way’ accounting for 0.1 to 1 z 1023 of the total ultrafiltration
coefficient has been invoked [11, 12]. Negative charges in the 50 Å
pores were assumed to be mainly responsible for the prevention of
albumin from leaking across the glomerular wall.
Dextran molecules are, however, long-chained flexible mole-
cules and new data using neutral cyclic molecules as probes for
glomerular permeability have indicated that the small-pore radius
may be rather of the order of 30 Å than 50 Å. Thus, the major
portion of albumin restriction seems to derive from size-selectivity
rather than from charge-selectivity of the glomerular capillary wall
[13]. Indeed, the charge-selectivity for anionic and neutral horse-
radish peroxidase was recently shown to be of the same order of
magnitude as that in peripheral capillaries. Thus, the glomerular
capillary wall anionic charge-barrier seems to have reduced the
clearance of negatively charged horseradish peroxidase only by a
factor 2 to 3 [14, 15].
The present study was performed in order to evaluate the size
of what has previously been known as ‘shunt pathways’ of
glomerular permselectivity. If such non-discriminatory pathways
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exist, then the fractional clearance of all proteins larger than a
certain large solute size would be about equal, which was tested in
the present study. To inhibit tubular reabsorption of large pro-
teins, we used lysine inhibition [10] in normal rats and in rats with
puromycin aminonucleoside (PAN)-induced nephrosis. The in-
vestigated proteins were represented by b2-microglobulin (mol
radius 16.2 Å), orosomucoid (mol radius 29 Å), albumin (mol
radius 36 Å), IgG2a (mol radius 55 Å) and a2-macroglobulin (mol
radius '90 Å). We were surprised to find a marked restriction of
large proteins across the glomerular capillary wall both during
normal conditions and in PAN nephrosis. Thus, if still existing,
classic shunt-pathways should contribute only at maximum '1025
of the entire glomerular filtration rate (GFR).
METHODS
Twenty-six female Wistar rats (Møllegard, Copenhagen, Den-
mark), weighing 185 to 270 g were divided into two groups. One
group, containing 10 animals, was given a single intraperitoneal
injection of PAN at 15 mg/100 g body wt (Sigma Chemical Co., St.
Louis, MO, USA). The drug was dissolved in one ml of 9 g/1000
ml sodium chloride [16–18]. No apparent acute toxic effects of
drug infusion were noted (see below). The remaining 16 animals
were left untreated. All the animals were allowed free access to
food and water. In the PAN treated group the experiments were
performed when the urinary protein, screened by urinalysis strips
for protein (Albustix®; Miles Inc., Ekhart, IN, USA), showed 41,
which occurred on day 9 to 11 after the injection of PAN. The
controls were used after 9 to 11 days.
Seven animals in the PAN group and 13 animals in the control
group were used in the experiments comprising measurements of
albumin, IgG2a, orosomucoid and b2-microglobulin. The remain-
ing three rats in each group were used in the experiments
comprising assessments of a2-macroglobulin.
All the animals were investigated according to the subsequent
protocol. Following induction of sodium pentobarbital anesthesia
(30 mg/kg body wt) the rats were placed on a temperature-
regulated table, which maintained rectal temperature at 37°C. The
blood vessels were cannulated using polyethylene tubing (PE-50):
the left internal jugular vein for infusing compounds, the left
carotid artery for obtaining blood samples and the tail artery for
continuous monitoring of blood pressure on a polygraph (Grass
model 7B; Grass Instrument Co., Quincy, MA, USA). Urinary
bladder was catheterized via the urethra using small tubing
(PE-50). After completion of the surgical preparation, which
required one to one and a half hours, the remainder of the
experiment lasted approximately four hours.
Experiments were initiated by a single injection of 50 ml of
51Cr-EDTA (10 mBq/ml; Amersham Radiochemical Centre, Ltd,
UK) dissolved in 0.3 ml saline. The injection was followed by
infusion at 100 ml 51Cr-EDTA (in 6 ml saline) 10 mBq/ml per
hour. After 60 minutes the infusion was supplemented by infusion
of L-lysine monohydrochloride (221 mmol/liter, 384 mOsm/liter;
Sigma), at 55 mmol/kg/min. The infusion was made by preparing
a solution of lysine (free base) in distilled water and adjusting the
pH to 7.4 with 1 N HCl acid. 51Cr-EDTA was given at the same
rate as before.
The dosage of lysine was calculated from pilot studies and from
literature [19–22]. Higher doses caused renal failure, since lysine
has been shown to be nephrotoxic [23]. Also, when the fluid
support to animals has been reduced, oliguria has usually oc-
curred after lysine administration [23].
An additional two rats were investigated according to the study
protocol in order to investigate the ultrastructural status of
glomerular and tubular epithelium after lysine infusion. The
animals were killed by intravenous injection of potasium-chloride,
whereupon the kidneys were dissected out and cut in slices, which
were immersion-fixed in a solution of 4% of buffered formalde-
hyde, and further processed for parafin embedding. Sections were
cut at a thickness of 4 mm, which were stained in hematoxylin and
eosin, Masson Trichrome alum, silver methenamine, Van Gieson,
picrosirius and Mac Manus.
Duplicate 10 ml samples of arterial blood were taken every 30
minutes for radioactivity measurements in vials prefilled with 0.5
ml of 0.9% sodium chloride. Samples (50 ml) for hematocrit were
collected every 60 minutes. Blood (0.5 ml) was drawn from the
arterial line at the end of each experiment for measurement of
protein concentrations. The blood samples were centrifuged for
12 minutes at 5000 r/min and the plasma was separated. Urine was
collected at 30 minute intervals from the urethra.
The fractional plasma clearance (u) was computed by the
formula:
u 5
Cu z Vu
C# p z GFR
and GFR was calculated from:
GFR 5
CuE z Vu
Cpw
where the plasma water concentration of CrEDTA (Cpw) was
obtained from:
Cpw 5
CpE
0.984 2 0.000718 z Cprot
where Cup and CuE are urinary concentration of protein and
CrEDTA, respectively, Vu represents urine flow per minute, Cprot
and CpE represents plasma concentration of protein and
CrEDTA, respectively, GFR was determined as the 51Cr-EDTA
plasma-to-urine clearance, and C# p (average plasma protein con-
centration in glomeruli) was calculated by the formula:
C# p 5
Cp 1 Cp z
1
1 2 FF z ~1 2 ui!
2
where Cp is protein content in plasma entering the glomeruli,
Cp z 1/(1 2 FF z (1 2 ui)) is the plasma protein concentration in
efferent plasma and ui is the sieving coefficient for proteins
in plasma before correction for the plasma concentration process
in glomeruli.
Determination of protein concentrations
The plasma and urine concentrations of albumin, IgG2a and
orosomucoid were determined by single radial immunodiffusion
[24] using, for albumin and IgG2a, monospecific rabbit anti-rat
antisera (Kemila, Sollentuna, Sweden), and for orosomucoid a
specially prepared rabbit anti-rat antisera (Agri Sera, Va¨nna¨s,
Sweden). Eight microliters of undiluted plasma or urine were
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used and the plates were incubated in a humid chamber at 8°C.
The incubation time was three days for albumin and orosomucoid
and ten days for IgG2a. Purified albumin, IgG2a and orosomucoid
(Sigma) were used as standards.
The plasma and urine concentrations of b2-microglobulin were
determined by the radioimmunosorbent technique and the pro-
tein was purified according to Berggård and Bearn [25].
a2-Macroglobulin (Scipac Limited, Sittingborn, UK) was frac-
tionated by gel chromatography using a Superose 6 gel filtration
column (Pharmacia Biotech, Sollentuna, Sweden). The fraction
containing a2-macroglobulin was bound to
125I (Kjeller, Norway)
by the Chloramine T method. The free 125I was reduced from
'2% to 0.2–0.5% using Amicon microfilters (Microcon 30).
Urine samples containing radioactive tracer were precipitated
using 10% trichloroacetic acid, and measurements were only
performed on the precipitate that was rinsed twice to completely
remove all free 125I from the pellet. Radioactivity was measured
using a gamma scintillator (Clini-Gamma - 1272; LKB-Wallac,
Turku, Finland).
Calculations
Analyses of glomerular clearances as a function of molecular
radius were performed according to the two-pore theory of
membrane permeability and were described in detail previously
[3, 26]. The formulas are presented in the Appendix.
In brief, clearances of all proteins larger than the assumed
small-pore radius, as predicted from sieving curves of the smallest
molecules investigated, can be shown to be determined solely by
convective processes, and hence, their large-pore clearances are
just products of the large-pore volume flow and the drag coeffi-
cients of the solutes [1–5, 8]. The small pore clearances can be
determined from the non-linear (Patlak) flux equation [27].
Calculations and data fits were performed on a personal
computer (Casio 880P) using an iterative procedure to get the
best curve fit to the experimental data.
Statistical methods
Renal function, plasma and urinary data are given as medians
and ranges. The Mann-Whitney U-test was used to compare sets
of analyses. The level of significance was P , 0.05.
RESULTS
Glomerular filtration rate (GFR) and plasma levels of proteins
in control rats and in nephrotic rats are shown in Table 1. The
median plasma-to-urine clearances for the investigated proteins
before and after lysine treatment in control rats are presented in
Table 2 and in rats with PAN induced nephrosis in Table 3. With
lysine treatment there was a statistically significant (P , 0.05)
increase in the clearances of proteins in normal rats compared to
the untreated animals. The clearance of large proteins increased
five- to sixfold, with an exception for the clearance of orosomu-
coid, which was just doubled. The b2-microglobulin clearance
increased by a factor of 450. Puromycin aminonucleoside nephro-
sis (PAN) resulted in a marked (150 times) increase of the
clearances of the large proteins. Lysine treatment of PAN ne-
phrotic rats, however, resulted only in a slight and non-significant
increase in clearances of these proteins.
In Figure 1 the measured plasma-to-urine clearances for the
investigated proteins are plotted versus molecular radius in a
semilogarithmic diagram and the data are analyzed using a
two-pore curve fit. We were surprised to find a relatively sharp
restriction of solute transfer as a function of increases in molec-
ular radius for both small and large pores. The small-pore radius
was determined to be 29 Å in all experiments. The large-pore
radius was determined to be 115 Å, and v0 to 1.7 z 10
24 in
lysine-treated normal rats and 110 Å and 2.5 z 1022 in lysine-
treated PAN nephrotic rats, respectively.
There is no direct indication for the presence of a shunt
pathway from our data. However, we had no ability to analyze
solutes larger than a2-macroglobulin in radius because of the
expected extremely low concentrations of such solutes. Thus, if
the presence of a shunt pathway is postulated, it could maximally
carry a flow of 2.89 z 1025 ml/min through the glomerular
membrane, corresponding to the clearance of a2-macroglobulin.
Therefore, if a shunt pathway of this type is invoked, the
large-pore estimate is reduced from 115 to 90 Å. Again, it should
be pointed out that such a shunt pathway cannot be directly
predicted from the present data.
In the PAN-induced nephrotic syndrome, where tubular reab-
sorption was inhibited and where v0 increased by a factor of 150,
the small-pore radius (29 Å) and large-pore radius (115 Å) were
Table 1. Glomerular filtration rate (measured as 51Cr-EDTA plasma
clearance) and plasma concentrations of b2-microglobulin, albumin,
orosomucoid and IgG2a in 16 control rats and in 10 rats with
puromycin aminonucleoside (PAN) induced nephrosis
Control rats median
(range)
PAN nephrosis
rats median
(range)
Plasma clearance of
51Cr-EDTA
1400 (1007–1868) 705 (314–917)
Plasma b2-
microglobulin mg/liter
4.6 (3.3–8.9) 1.9 (1.5–2.5)
Plasma albumin mg/liter 22020 (16320–25200) 4937 (3200–6720)
Plasma orosomucoid
mg/liter
115 (69–216) 14 (7–22)
Plasma IgG2a mg/liter 1156 (880–1566) 66 (26–98)
Table 2. Medians (ranges) of fractional plasma-to-urine clearances for
b2-microglobulin, orosomucoid, albumin, IgG2a and a2-macroglobulin in
control rats before and after treatment with lysine
Protein Before lysine treatment Lysine treated rats
b2-Microglobulin 2.89
24 (1.2124–9.0524) 1.3021 (7.1822–2.4721)
Orosomucoid 1.6724 (6.1625–5.8924) 3.4024 (1.3324–1.2923)
Albumin 5.3925 (2.5625–1.1324) 3.3124 (1.1724–9.2124)
IgG2a 3.59
25 (1.6625–1.1324) 1.5824 (9.7125–3.0724)
a2-Macroglobulin 4.85
26 (1.8126–8.2526) 2.8925 (1.7325–5.0625)
Table 3. Medians (ranges) of fractional plasma-to-urine clearances for
b2-microglobulin, orosomucoid, albumin, IgG2a and a2-macroglobulin in
puromycin aminonucleoside (PAN) nephrosis rats before and after
treatment with lysine
Protein Before lysine treatment After lysine treatment
b2-Microglobulin 1.20
21 (8.8922–2.1421) 5.18
21
(2.7521–9.0321)
Orosomucoid 4.1822 (2.4022–7.5622) 6.0922 (3.6922–7.5622)
Albumin 3.8322 (2.0322–7.9722) 5.9122 (3.2022–3.2121)
IgG2a 2.26
22 (8.3723–6.9822) 2.7922 (1.6122–4.5322)
a2-Macroglobulin 1.51
23 (7.4824–1.5523) 5.1623 (4.2523–6.4123)
Tencer et al: Size selectivity of the glomerular filter 711
unchanged compared to controls. Indeed, in the nephrotic syn-
drome the number of large-pores increased 170-fold while the
small-pore system was more or less unaffected. The ratio between
the number of large-pores and small-pores is according to
Porseuille’s law:
nL
nS
5
v0
1 2 v0
S rSrLD
4
This ratio was calculated to be '6.9 z 1027 normally and, thus
increased to 1.03 z 1024 in the nephrotic syndrome.
The tissue studies of the kidneys of the lysine-treated rats
compared to untreated animals showed that the cytoplasm of the
tubular epithelium was vacuolated and contained large amounts
of silver-positive protein resorption droplets. In contrast, the
appearance of the glomeruli was not different from that in normal
animals.
DISCUSSION
The two-pore model of capillary permeability has been success-
fully applied to describe the blood-tissue transfer of small and
large solutes in a large number of different organs [1–3]. Charac-
teristically the large-pore radius has been found to be of the order
of 250 Å in most continuous and fenestrated vascular beds, as
judged from lymphatic flux analyses. To make such analyses one
has to assess the filtrate-to-plasma concentration ratios of very
large solutes, such as a2-macroglobulin and IgM. However, with
regard to glomerular permselectivity, most analyses do not include
measurements of such large macromolecules. Most fractional
clearances (or ultrafiltrate-to-plasma concentration ratios) have
been analyzed for solutes up to the size of 60 to 70 Å [11]. Thus,
they have often been assigned an infinite size, but larger than 80
Å [28]. Only very seldom have larger molecules been assessed.
Still, glomerular permselectivity is nowadays usually analyzed
Fig. 1. Measured fractional plasma to urine clearances of b2-microglobulin, orosomucoid, albumin, IgG2a, and a2-macroglobulin versus molecular
radius in a semilogarithmic diagram. The data are analyzed using a two-pore curve fit. Lines are: (solid) PAN 1 lysine; (dotted) control 1 lysine.
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using a heteroporous concept, the large pores usually denoted as
‘shunt-pathways’ [12]. Strictly speaking, however, ‘shunt pathways’
denote pathways through which the fractional clearance of solutes
above a certain size should be constant, but recent studies indicate
that this may not be true [13, 29].
We performed the present study to get more insight into the
size of the large-pore population in the glomerular barrier by
analyzing urine protein fluxes after inhibition of proximal tubular
protein reabsorption using lysine. Our data indicate that there are
normally no non-discriminatory shunt pathways in the glomerular
barrier, at least not of functional importance. If still existing, they
may at maximum contribute 1025 of the total glomerular hydrau-
lic conductance (Kf).
The present data are not directly comparable to data obtained
by glomerular sieving of neutral dextrans. Neutral dextrans are
not spherically shaped, but are characterized by an elongated
shape with a random-coil configuration. Endogenous macromol-
ecules should be more ideal test probes for evaluating glomerular
selectivity. Also, Ficoll, which is spherical in shape, has been
recently used to compute membrane pore size parameters. These
new measurements of size selectivity characteristically yield a
small-pore radius of around 30 Å [11]. The main purpose of this
study was to determine the radius of the large pores rather than
the small pores’ radius. However, according to our calculations,
the effective, equivalent, small pore radius can at maximum be 29
Å, corresponding to a maximal uncharged radius of 44 to 45 Å.
According to the Debye-Hu¨ckel theory of charged solute interac-
tions, a 29 Å (radius) molecule will behave as a 37 Å (5 29 1 8)
uncharged molecule, and a 45 Å (radius) pore will behave as a 37
Å (5 45 2 8) uncharged pore [30]. Since albumin has a molecular
radius of 36 Å, it should normally not be able to filter through the
small pores, or at least a majority of small pores, but should share
more or less the same pathway as IgG and other large macromol-
ecules. However, this pathway cannot be a shunt pathway, because
in that case, large IgG losses to the urine should always be
accompanied by significant urinary losses of even larger proteins,
such as a2-macroglobulin and IgM. This is almost never seen
clinically. In the nephrotic syndrome, however, the fractional
excretion of albumin and IgG is usually increased in parallel [31]
(unpublished data), indicating an increased number of size-
discriminative large-pore pathways shared by both albumin and
IgG.
One implication of the presence of size-discriminative large
pores in the glomerular filter is that, among other things, IgM will
not pass the glomerular filter under normal conditions at all.
Indeed, nearly all significant amounts of a2-macroglobulin and
IgM that are excreted to the urine should be derived from
postrenal sources [32]. The present data cannot, however, rule out
the presence of a very small number of shunt pathways accounting
for at maximum 2 z 1025 of the total filtration rate. In that case the
dominant large-pore pathway, besides the 29 Å small-pores, is a
90 Å large-pore from which a2-macroglobulin is totally excluded.
If the large-pore size is of the order of 90 to 115 Å, then an
electrical charge will indeed affect transport across these pores,
unlike the situation in 250 Å pores or shunt pathways. Both
charge-selectivity and size-selectivity are thought to affect the
transport of large molecules across the glomerular membrane.
However, in the present PAN induced nephrosis, u for albumin
and u for IgG increased in parallel, suggesting that charge
alterations did not occur in the present experiments.
Lysine inhibition of proximal tubular reabsorption of proteins is
usually considered to be more or less complete [10]. In the present
experiments most macromolecule studied increased their clear-
ance to the final urine by a factor five to six, while the change for
b2-microglobulin was 450-fold. Still, we expected further inhibi-
tion. The morphology studies that we performed on kidneys of
lysine treated rats showed no glomerular pathology.
Another way of reducing the impact of proximal tubular
reabsorption on protein transfer to the final urine is to saturate
the reabsorption mechanism via the induction of massive protein-
uria. Thus, ten rats were treated by PAN and investigated in
exactly the same way as the control lysine-treated rats. We were
surprised to find almost exactly the same protein excretion pattern
as a function of molecular radius in both the lysine treated groups,
except that large pore transport was greatly enhanced in the PAN
nephrosis rats. This indicates that even though the lysine inhibi-
tion may not have been absolutely complete, the excretion pattern
(and large-pore estimate) was similar in the two situations when
tubular reabsorption was inhibited in different ways. Further-
more, the sieving coefficient for albumin obtained after lysine
infusion in control rats was not very different from that obtained
in isolated perfused kidneys where the tissue temperature had
been reduced to 8°C, which should cause complete inhibition of
proximal tubular reabsorption [4, 5]. We therefore feel quite
confident that the pattern of clearance versus molecular radius
found in the present study really mimics the normal sieving
pattern in the Bowman’s capsule ultrafiltrate. At most, the real
ultrafiltrate concentration of proteins may be approximately 30 to
40% higher in absolute terms than measured in the present study.
However, there is no reason to believe that the relative sieving
pattern should be markedly different than that measured in the
current study.
The present data may also be simulated using a log-normal
(plus shunt) model. Such a model would, however, not give such
a distinct sieving pattern for solutes ranging in size between 20
and 30 Å. However, applying this model the average equivalent
pore size will be reduced from '30 Å to '20 to 25 Å. Since we
lack the computer program to do these simulations, we have
chosen not to apply the distributed model in the present pore
estimations.
In summary, we have found a clear-cut size-restriction of
molecules larger than albumin across the glomerular barrier,
indicating the presence of ‘large pores’ in the glomerular mem-
brane and not infinite ‘shunt pathways.’ Since the large pores have
a smaller radius than previously thought, charge selectivity should
be of importance not only in the small pores but also for
macromolecular transport across the large pores [33, 34]. More-
over, if classic shunt pathways still exist, they contribute less than
1025 of the total GFR. The major implications of our findings are
that very large macromolecules like IgM will not pass the glomer-
ular filter under normal conditions at all, whereas a2-macroglob-
ulin will appear only in extremely low concentrations. If IgM (or
a2-macroglobulin) appear in the appreciable amounts in the urine
they can be expected to have been derived from postrenal sources
rather than from glomerular filtration.
APPENDIX
Clearances of all proteins larger than the assumed small-pore
radius, as predicted from sieving curves of the smallest molecules
investigated, can be shown to be determined solely by convective
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processes (see below), and hence, their large-pore clearances
(ClL) are just products of the large-pore volume flow (JvL) and the
drag coefficients (1-s) of the solutes [1–5, 8]:
ClL 5 JvL~1 2 s!L (Eq. 2a)
where s denotes the reflection coefficient of the membrane to the
particular solute. The sieving coefficient (u) is then:
u 5
JvL
GFR
~1 2 s!L (Eq. 2b)
Here (1 2 s)L is determined in terms of solute radius (ae) over
the large pore radius (rL), denoted l, as can be described by
current hydrodynamic theories for s. Thus, according to the study
of Mason, Wendt and Bresler [35] we have:
1 2 s 5
~1 2 l!2@2 2 ~1 2 l!2#~1 2 l/3!
1 2 l/3 1 2/3l2
(Eq. 3)
Hence, if the clearances of at least two solutes larger than the
small-pore radius are measured it is possible from equations 2a
and 3 (or Eq. 2b and 3) to determine both JvL (or u) and rL.
Small-pore volume flow (JvS) is obtained by just subtracting JvL
from GFR.
Knowing JvL and the hydraulic conductance of the membrane,
it is possible to calculate the fractional hydraulic conductance
accounted for by the large pores (v0) using the following equation
[3, 26]:
JvL 5 v0~1 2 v0!Kf~1 2 sL!Dp 1 v0GFR (Eq. 4)
Here Kf is the hydraulic conductance of the glomerular mem-
brane, sL is the protein reflection coefficient for albumin through
large pores, and Dp is the transvascular osmotic pressure gradient,
which is equal to '26 mm Hg for a plasma colloid osmotic
pressure of 22 to 23 mm Hg in rats (that is, lower than in humans).
At a GFR of 1.4 ml/min, as in this study, Kf can be calculated to
be approximately 0.14 ml/min/mm Hg, assuming a net transglo-
merular pressure gradient of 10 mm Hg in our rats. One then
arrives at exactly the same Kf value per nephron (30,000
nephrons/rat) as obtained by Bohrer et al [36]. Inserting this value
into 4, for example (which is a quadratic expression), for a JvL of
0.00065 ml/min yields v0 5 1.7 3 10
24.
We now turn to the small pore clearances (ClS). These clear-
ances can be determined from the non-linear (Patlak)-flux equa-
tion [27]
ClS 5 JvS~1 2 s!
1 2 ~Cu/Cpw!e2Pe
1 2 e2Pe
(Eq. 5)
where Pe, which represents a modified Peclet number, is defined
as:
Pe 5
JvS~1 2 sS!
PSS
and PSS (the solute permeability-surface area product in small
pores) is defined as:
PSS 5
DS
DX
A 5
DS
DX
A
A0
A0 5 DS
A0
DX
A
A0
(Eq. 6)
where A represents the effective pore area available for restricted
diffusion and A0 is the total unrestricted cross-sectional pore area,
and
A
A0
is a term describing the diffusion restriction of a solute
in a (cylindrical) pore.
A0
DX
represents the unrestricted pore area
over unit diffusion distance. The free solute diffusion coefficient
Ds is defined by:
DS 5
RT
6p z N z ae z h
(Eq. 7)
Here RT is the product of the universal gas constant and the
temperature in degrees Kelvin, and finally, N is Avogadro’s
number, while h is water viscosity (0.00721 dynes z s21 z cm22).
A
A0
is determined by the solute radius over small-pore radius SaersD .
We employed the expression [35]:
A
A0
5
~1 2 l!9/2
1 2 0.3956l 1 1.0616l2
(Eq. 8)
to model the diffusion restriction as a function of solute radius
over pore radius.
A0
DX
can, according to pore theory, be deter-
mined using the following equation:
A0
DX
5
8hKf
r2 z 60 z 1,320
(Eq. 9)
Here, 1,320 is a factor converting millimeters of mercury (mm
Hg) into dynes per square centimeter, while 60 converts minutes
to seconds. Kf represents the hydraulic conductance (the product
of hydraulic conductivity and membrane surface area).
Thus, for rS 5 29 (Å) (see below) and Kf 5 0.14 ml/min/mm Hg
we can determine
A0
DX
to 1.177 z 106 cm. Alternatively,
A0
DX
and rS
can be determined as the best fit to experimental data of a specific
(small pore) clearance versus mol radius curve.
According to Porseuille’s law, the fractional large pore to small
pore surface area ratio SALASD is determined by v0, rS and rL
according to:
AL
AS
5
v0
1 2 v0
S rSrLD
2
(Eq. 10)
Hence, for rS5 29 (Å), rL 5 110 (Å) and v0 5 0.00017 and
AL/AS becomes 1.18 z 10
25 and
A0
DX
for the large pore system 5
13.82 (cm). It is now possible to test the validity of equations 2a
and 2b versus equation 5, as applied for the large pore system. It
is then evident that transport through large pores is convective to
its nature. Thus, for albumin the Peclet number becomes 3.23 and
for IgG2a 10.7, that is, both above 3, indicating convection
dominated transport.
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